Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits
The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.
Jessica Allegretti David Lee Walterk Jessica Allegretti Kunzmannk Guselkumab Drug Administration American College Of Gastroenterology
Source: hcplive.com